Login to Your Account

ADA 2012 Scientific Sessions

Sanofi Files for Lixisenatide OK in Japan, Awaits EU Decision

By Cormac Sheridan
Staff Writer

Tuesday, June 12, 2012
With its diabetes drug lixisenatide already undergoing regulatory review in Europe, Sanofi SA disclosed Monday, during the American Diabetes Association (ADA) meeting in Philadelphia, that it has now filed for regulatory approval in Japan.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription